A comparative study for GLP-1 levels in Iraqi diabetic patients with hyper & hypothyroidism
DOI:
https://doi.org/10.36320/ajb/v10.i1.8205Abstract
The current study aimed to determine GLP-1 levels in hyper and hypothyroidism disease with diabetic and compared the results with a control group. The study also aimed to find the relationship for GLP-1 with (TSH, T3and insulin) in patients groups. The study involved 30 subjects with hyperthyroidism and diabetic as group 1(G1), and 30 subjects hypothyroidism patients with diabetes as group 2 (G2) to 30 healthy controls as group 3 (G3). The subjects were matched aged of (40-65 years). Serum used in determination T3, TSH, FBG and insulin in the control and patients groups, the BMI and IR were also calculated. Results showed highly significant increase in T3 levels in G1 contrast to G3 while there are no significant decreasing was found in G2 contrast to G3.Results in this study revealed highly significant decreasing in TSH levels in G1 contrast to G3 with highly significant increase in G2 comparing to G3. Results illustrate levels of FBG in all studied groups, which showed highly significant increase in FBG in G1 and G2 comparing to G3. Results showed highly significant increase in insulin levels in G1 contrast to G3 while there are no significant different observed in G1 contrast to G2. Results, also, showed highly significant increasing in GLP-1 in G1 and G2 when compared to G3.Correlation relation of GLP-1with T3, TSH and insulin were studied. Result revealed significant positive correlation between GLP-1 and T3 in G3 (P≤0.5, r = 0.350) while a significant negative correlation was observed in G1 and G2 (P≤0.05, r = -.047, r = -0.55). Results revealed significant positive correlation in G3 between TSH and T3 (P≤0.05, r = -.055) while a significant negative correlation (P≤0.05, r = -.047, r =.386) was observed in G1 and G2. Study also showed the correlation relation between GLP-1 and insulin there are no significant positive relation was seen in G3 (P˃0.05, r = 0.083), while showed highly significant positive correlation in G1 and G2 (r = 0.55, r = 0.344). It is Concluded from this study that GLP-1 can be used as a marker in diagnostic and monitoring the development in diabetes to its complication in these patients.
Downloads
References
Mirella Hage,Mira S. Zantout, and Sami T. Azar,2011 Thyroid Disorders and Diabetes Mellitus Division of Endocrinology, Department of Internal Medicine, American University of Beirut-Medical Center.
Ray S, Ghosh S (2016) Thyroid Disorders and Diabetes Mellitus: Double Trouble J Dia Res Ther 2(1): doi Journal of Diabetes Research and Therapy
Meara N. M. O , Blackman J. D., J. Sturis, and K. S. Polonsky, 1993Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism,” Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 1, pp. 79–84.
Leong K. S., Wallymahmed, M., .Wilding.J, and MacFarlane, I. 1999“Clinical presentation of thyroid dysfunction and Addison’s disease in young adults with type 1 diabetes,” Postgraduate Medical Journal, vol. 75, no. 886, pp. 467–470.
Brubaker, P.L.2012 Regulation of intestinal GLP-1 Endocrinology. 2012; 1283175-3175-3182.
Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, et al. (2010) Glucagon like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology 51: 1584-1592.
(Glucagon.com 2015).
Toft- Nielsen, M.B., Dambholt, M.B and Hilsted.2012 Determinants of impaired GLP-1 secretion in type 2 diabetic patients. J.Clin. Endocrinol. Metab., 2012; 86(8):3717-3723.
Caryon P., Niccoli-sire P., Lejeune P. J., et al. (2002). Thyroid gland. Ann. Biol. Clin.; p.60.
Trinder , P. , et al. (1969) . Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clinic. Biochem. ; 6. PP: pp: 24-27
Wondisiford F. E., Toft A. D., and Weintraub B. D., (1996).Chemistry and Biosynthesis of Thyotropin. In Braverman L.E. and Utiger R.D. eds. Werner and Ingbar′s the Thyroid, 7th edition: pp: 190-207. Philadelphia, Lippincott-Raven.
Pharmacology, physiology, and mechanisms of incretin hormone action Cell Metab. 2013 Jun 4; 17(6):819-37
Owen WE, Roberts WL.2004 Letter to the Editor: Cross-Reactivity of Three Recombinant Insulin Analogs with Five Commercial Insulin Immunoassays. Clin Chem; 50(1):257-259.
Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Hideki T, Komatus M, Morioka T, Shoji T, Okunoy Y, Nishizawa Y, 2003 Qualitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal rang weight and moderately obese type 2 diabetic patients diabetes care 26:2426-2432.
Hanne F. Fleiner Trine Bjøro Kristian Midthjell Valdemar Grill Bjørn O. Åsvold 2016 .Prevalence of Thyroid Dysfunction in Autoimmune and Type 2 Diabetes: The Population-Based HUNT Study in Norway The Journal of Clinical Endocrinology & Metabolism, Volume 101, Pages 669–677.
W. Becker, R. Kluge, T. Kantner et al., 2004 “Differential hepatic gene expression in a polygenic mouse model with insulin resistance and hyperglycemia: evidence for a combined transcriptional dysregulation of gluconeogenesis and fatty acid synthesis,” Journal of Molecular Endocrinology, vol. 32, no. 1, pp. 195–208.
C. N.Mariash, C. R.McSwigan, H. C. Towle, H. L. Schwartz, and J. H. Oppenheimer, 1981 “Glucose and triiodothyronine both induce malic enzyme in the rat hepatocyte culture: evidence that triiodothyronine multiplies a primary glucose-generated signal,” Journal of Clinical Investigation, vol. 68, no. 6, pp. 1485–1490,.
L. P. Klieverik, S. F. Janssen, A. Van Riel et al., “Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5966–5971, 2009.
Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, et al. (2006) Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab. 91: 4930-4937.
Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, et al. (2007) Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet Med. 24: 1336-1344.
Mitrou P, Boutati E, LambadiariV, Tsegka A, Raptis AE, et al. (2010) Insulin resistance in hyperthyroidism: the role of IL6 and TNF alpha. Eur J Endocrinol 162: 121-126.
Stanicka S, Vondra K, Pelikanova T, Vlcek P, Hill M, et al. (2005) Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy. Clin Chem Lab Med 43: 715-720.
Fernandez-Real JM, Lopez-Bermejo A, Castro A, Ricart W (2006) Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 91: 3337–3343.
Baskin HJ, Cobin RH, DuickDS, Gharib H, Guttler RB, et al. (2002) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8 :457–469.
G. D. Dimitriadis, B. Leighton, M. Parry-Billings, D. West, and E. A1989. Newsome, “Effects of hypothyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat,” Biochemical Journal, vol. 257, no. 2, pp. 369–373,
Dimitriadis G., Parry-Billings M., Bevan S. et al. 1997. “The effects of insulin on transport and metabolism of glucose in skeletal muscle from hypothyroid rats,” European Journal of Clinical Investigation, vol. 27, no. 6, pp. 475–483.
Dimitriadis G., Mitrou P., Lambadiari V. et al., “Insulin action in adipose tissue and muscle in hypothyroidism,” Journal of Clinical Endocrinology &Metabolism, vol. 91, no. 12, pp. 4930–
inman B, et al. 2015 Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes. .N Engl J Med; 373:2117–28.)
(NICE. Type 2 diabetes in adults: Management. NG28. December 2015.)
Ko¨ rner M, Sto¨ ckli M, Waser B, Reubi JC 2007 GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48:736–743
Hirsch PF, Baruch H 2003 Is calcitonin an important physiological substance? Endocrine 21:201–208
Wang W, Lewin E, Olgaard K 2002 Role of calcitonin in the rapid minute-to-minute regulation of plasma Ca2_ homeostasis in the rat. Eur J Clin Invest 32:674–681
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Zeinab Moneb. Al-Rubaei, Usama Salman. Al timari, Huda Ahmed. Alobaydi
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
